BXP vs CCEL · rev $3.48B vs P/E 490, $39.6M cap
Boston Properties Inc (BXP) versus CryoCell International Inc (CCEL) — a side-by-side from cached financials, not a winner call.
Boston Properties Inc (BXP) is a reit - office company listed on US.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Latest reported BXP revenue for 2025-12-31 was $3.48B. Net income was $276.8M. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BXP currently screens at market cap $12.12B.
CCEL does not have a complete income-statement cache yet.
BXP currently screens at market cap $12.12B. CCEL currently screens at market cap $39.6M and trailing P/E 490.0.
Not investment advice. Open the BXP and CCEL stock pages for the full models.
Not investment advice.